Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Capsum has 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 6 distinct examiners across 4 distinct art units. This distribution shows that every one of the 6 pending office actions is assigned to a different individual examiner.
The busiest examiner is LAZARO, DOMINIC, who is responsible for 1 of the 6 pending office actions. Since there are 6 distinct examiners for 6 actions, each examiner is managing exactly 1 case. This means the company must engage with 6 different officials for its current active portfolio. Practitioners should be prepared for 6 unique prosecution styles across the 6 pending office actions.
The 6 pending office actions are spread across 4 distinct art units, which suggests technical variety within the Biotechnology & Pharmaceuticals sector. While the 6 distinct examiners will each have their own approach, the distribution across 4 art units may lead to different examination standards. Practitioners should be prepared for 6 different sets of examiner feedback across the 4 distinct art units. The lack of examiner-level consolidation means that each of the 6 pending office actions must be prosecuted with a unique focus. LAZARO, DOMINIC, as the busiest examiner with 1 action, represents the even spread of the current workload.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (43%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOYER, CHARLES I | 1 | 70.4% | +19.7% |
| LAZARO, DOMINIC | 1 | 63.7% | +31.2% |
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
| LIPPERT, JOHN WILLIAM | 1 | 59.2% | +39.9% |
| CRAIGO, WILLIAM A | 1 | 48.9% | +38.1% |
| LIU, SUE XU | 1 | 20.9% | +18.6% |
| SARANTAKOS, KAYLA ROSE | 1 | 37.1% | +49.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18584735 | Product comprising a liquid composition and a solid composition comprising at least one cavity | LIU, SUE XU | 41d |
| 18859866 | SOLID COSMETIC CARE COMPOSITION COMPRISING AT LEAST ONE CAVITY | SCOTLAND, REBECCA LYNN | — |
| 18658601 | COSMETIC FRAGRANCE COMPOSITION IN THE FORM OF AN ALCOHOL-FREE EMULSION | CRAIGO, WILLIAM A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251833 | DEVICE FOR DECONTAMINATING A HOLLOW OBJECT DEFINING AN INTERNAL CAVITY, AND ASSOCIATED DISPENSING MACHINE AND METHOD | SARANTAKOS, KAYLA ROSE | 8d overdue |
| 18584735 | Product comprising a liquid composition and a solid composition comprising at least one cavity | LIU, SUE XU | 41d |
| 18879666 | SOLID CLEANING COMPOSITION HAVING AT LEAST ONE CAVITY | BOYER, CHARLES I | — |
| 18860338 | SOLID COSMETIC COMPOSITION COMPRISING AT LEAST ONE CAVITY | LAZARO, DOMINIC | — |
| 18712621 | MACROSCOPIC DISPERSION WITH A DISPERSED FATTY PHASE HAVING HIGH CATIONIC POLYMER AND PIGMENT CONTENT | LIPPERT, JOHN WILLIAM | — |
| 18658601 | COSMETIC FRAGRANCE COMPOSITION IN THE FORM OF AN ALCOHOL-FREE EMULSION | CRAIGO, WILLIAM A | — |
| Art Unit | Apps |
|---|---|
| 1615 | 3 |
| 1761 | 1 |
| 1611 | 1 |
| 1616 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18879666 | SOLID CLEANING COMPOSITION HAVING AT LEAST ONE CAVITY | BOYER, CHARLES I | 1761 | §103 | Non-Final OA | — | Pending | Dec 27, 2024 |
| 18860338 | SOLID COSMETIC COMPOSITION COMPRISING AT LEAST ONE CAVITY | LAZARO, DOMINIC | 1611 | §102§103§112DP | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18859866 | SOLID COSMETIC CARE COMPOSITION COMPRISING AT LEAST ONE CAVITY | SCOTLAND, REBECCA LYNN | 1615 | §103§112Other | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18712621 | MACROSCOPIC DISPERSION WITH A DISPERSED FATTY PHASE HAVING HIGH CATIONIC POLYMER AND PIGMENT CONTENT | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | — | Pending | May 22, 2024 |
| 18658601 | COSMETIC FRAGRANCE COMPOSITION IN THE FORM OF AN ALCOHOL-FREE EMULSION | CRAIGO, WILLIAM A | 1615 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18584735 | Product comprising a liquid composition and a solid composition comprising at least one cavity | LIU, SUE XU | 1616 | §102§103§112Other | Non-Final OA | 41d | Pending | Feb 22, 2024 |
| 18251833 | DEVICE FOR DECONTAMINATING A HOLLOW OBJECT DEFINING AN INTERNAL CAVITY, AND ASSOCIATED DISPENSING MACHINE AND METHOD | SARANTAKOS, KAYLA ROSE | 1799 | §103 | Non-Final OA | 8d overdue | Pending | May 04, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCapsum has 7 pending office actions as of October 2026, spread across 5 art units and 7 examiners.
Charles I Boyer has the most, with 1 of Capsum's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
